[Risk stratification of sudden death in hypertrophic cardiomyopathy in 2016]

Area of Science:

• Cardiology
• Genetics
• Clinical Medicine

Background:

• Hypertrophic cardiomyopathy (HCM) patients face elevated mortality risks, including sudden cardiac death (SCD).
• Identifying SCD risk factors is crucial for patient management and preventative strategies.

Purpose of the Study:

• To outline key risk factors for sudden cardiac death in hypertrophic cardiomyopathy patients.
• To discuss current approaches to risk stratification for SCD in HCM.
• To emphasize the need for improved risk stratification to guide implantable cardioverter-defibrillator (ICD) therapy.

Main Methods:

• Review of established risk factors for SCD in HCM.
• Comparison of classical risk stratification methods with newer risk-calculator approaches.
• Discussion of clinical indicators such as family history, syncope, ventricular tachycardia, blood pressure response to stress, and left ventricular hypertrophy.

Main Results:

• Major risk factors for SCD in HCM include family history, syncope/dizziness, non-sustained ventricular tachycardia, abnormal stress test blood pressure response, and severe left ventricular hypertrophy (≥30mm).
• Both classical risk factor assessment and the ESC-recommended risk calculator are valuable, complementary tools for risk stratification.
• Current risk stratification methods require further refinement to optimize the selection of high-risk patients for ICD implantation.

Conclusions:

• Accurate risk stratification is essential for managing SCD risk in both symptomatic and asymptomatic HCM patients.
• A combination of traditional risk factors and modern calculators improves risk assessment.
• Enhanced risk stratification models are needed to ensure appropriate ICD implantation in hypertrophic cardiomyopathy.